TELADOC HEALTH, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
TELADOC HEALTH, INC. (TDOC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-02-26
- TELADOC HEALTH, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- TELADOC HEALTH, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- TELADOC HEALTH, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- TELADOC HEALTH, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-03-31 was 32.48K shares, a 58.96% increase year-over-year.
- TELADOC HEALTH, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 0.00 shares, a 100.00% decline from fiscal 2024.
- TELADOC HEALTH, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 32.48K shares, a 88.24% decline from fiscal 2023.
- TELADOC HEALTH, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 276.27K shares.
- TELADOC HEALTH, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2016 was 3.91M shares, a 156.83% increase from fiscal 2015.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2025-12-31 | 0.00 shares 10-K · filed 2026-02-26 | |||
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 0.00 shares derived: sum of 2 quarters · filed 2025-02-27 | 0.00 shares derived: sum of 3 quarters · filed 2025-02-27 | 32.48K shares 10-K · filed 2025-02-27 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | 0.00 shares derived: sum of 2 quarters · filed 2024-10-31 | 32.48K shares 10-Q · filed 2024-10-31 | 221.20K shares derived: sum of 4 quarters · filed 2024-10-31 |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | 32.48K shares 10-Q · filed 2024-08-01 | 221.20K shares derived: sum of 3 quarters · filed 2024-08-01 | 249.07K shares derived: sum of 4 quarters · filed 2024-08-01 |
| 2024-03-31 | 32.48K shares 10-Q · filed 2024-04-26 | 221.20K shares derived: sum of 2 quarters · filed 2024-04-26 | 249.07K shares derived: sum of 3 quarters · filed 2024-04-26 | 288.32K shares derived: sum of 4 quarters · filed 2024-04-26 |
| 2023-12-31 | 188.72K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | 216.59K shares derived: sum of 2 quarters · filed 2024-02-23 | 255.84K shares derived: sum of 3 quarters · filed 2024-02-23 | 276.27K shares 10-K · filed 2024-02-23 |
| 2023-09-30 | 27.88K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | 67.12K shares derived: sum of 2 quarters · filed 2023-10-27 | 87.55K shares 10-Q · filed 2023-10-27 | |
| 2023-06-30 | 39.25K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | 59.68K shares 10-Q · filed 2023-07-28 | ||
| 2023-03-31 | 20.43K shares 10-Q · filed 2023-05-02 | |||
| 2022-09-30 | 18.14K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | 1.41M shares 10-Q · filed 2022-11-02 | ||
| 2022-06-30 | 1.39M shares 10-Q · filed 2022-08-03 | |||
| 2016-12-31 | 3.91M shares 10-K · filed 2017-03-01 | |||
| 2015-12-31 | 1.52M shares 10-K · filed 2017-03-01 | |||
| 2014-12-31 | 1.57M shares 10-K · filed 2017-03-01 | |||
| 2013-12-31 | 736.40K shares 10-K · filed 2016-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |